Franklin Resources
BBIO icon

Franklin Resources’s BridgeBio Pharma BBIO Stock Holding History

Franklin Resources’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$161M Sell
2,160,173
-278,752
-11% -$19.5M 0.03% 354
2026
Q1 		$181M Buy
2,438,925
+273,997
+13% +$19.9M 0.04% 317
2025
Q4 		$166M Buy
2,164,928
+720,905
+50% +$47.3M 0.04% 343
2025
Q3 		$75M Buy
1,444,023
+622,618
+76% +$30.4M 0.02% 509
2025
Q2 		$35.5M Buy
821,405
+482,149
+142% +$17.5M 0.01% 739
2025
Q1 		$11.7M Buy
339,256
+330,658
+3,846% +$11.1M ﹤0.01% 1059
2024
Q4 		$236K Buy
8,598
+1,698
+25% +$43.9K ﹤0.01% 2600
2024
Q3 		$178K Hold
6,900
– – ﹤0.01% 2662
2024
Q2 		$175K Buy
6,900
+2,351
+52% +$64.3K ﹤0.01% 2585
2024
Q1 		$141K Buy
+4,549
New +$155K ﹤0.01% 2662
2022
Q1 		– Sell
-286,837
Closed -$4.78M – 2444
2021
Q4 		$4.78M Buy
286,837
+1,505
+0.5% +$63.7K ﹤0.01% 1232
2021
Q3 		$13.4M Buy
285,332
+1,842
+0.6% +$98.7K 0.01% 991
2021
Q2 		$17.3M Sell
283,490
-609
-0.2% -$34.8K 0.01% 894
2021
Q1 		$17.5M Buy
284,099
+30
+0% +$1.96K 0.01% 865
2020
Q4 		$20.2M Buy
284,069
+584
+0.2% +$28.2K 0.01% 814
2020
Q3 		$10.6M Buy
283,485
+185
+0.1% +$5.82K 0.01% 891
2020
Q2 		$8.75M Hold
283,300
– – ﹤0.01% 896
2020
Q1 		$8.22M Hold
283,300
– – 0.01% 837
2019
Q4 		$9.93M Sell
283,300
-66,700
-19% -$1.85M 0.01% 895
2019
Q3 		$7.51M Hold
350,000
– – ﹤0.01% 926
2019
Q2 		$9.44M Buy
+350,000
New +$9.54M 0.01% 902

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Franklin Resources's BBIO Position: Q2 2026 in Review

Franklin Resources reduced its BridgeBio Pharma (BBIO) stake by 11% in Q2 2026, selling an estimated $19.5M and leaving 2,160,173 shares worth $161M. The position accounts for 0.03% of the portfolio, ranked #354.

Franklin Resources first reported a position in BBIO in Q2 2019 and has held it in 21 quarters since. The position peaked at $181M in Q1 2026. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Franklin Resources held 2,160,173 shares of BridgeBio Pharma worth $161M as of Q2 2026.
  • Franklin Resources sold 278,752 BridgeBio Pharma shares in Q2 2026, an estimated $19.5M.
  • BridgeBio Pharma made up 0.03% of Franklin Resources's portfolio in Q2 2026, its #354 holding.
  • Franklin Resources first reported a position in BridgeBio Pharma in Q2 2019 and has held it in 21 quarters since.
  • Franklin Resources's BridgeBio Pharma position peaked at $181M in Q1 2026.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.